Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 131

    1.

    Severe exertional dyspnea as the prime manifestation of acute cytomegalovirus infection in an immunocompetent adult.

    Pagourelias ED, Papageorgiou A, Basayannis E, Athyros VG, Karagiannis A, Zorou P, Geleris P.

    Hippokratia. 2009 Jul;13(3):181-3.PMID: 19918310 [PubMed - in process]Related articles

    2.

    Dyslipidemia as a Risk Factor for Ischemic Stroke.

    Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP.

    Curr Top Med Chem. 2009;9(14):1291-1297.PMID: 19849661 [PubMed - as supplied by publisher]Related articles

    3.

    Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management.

    Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP.

    Nutr Metab Cardiovasc Dis. 2009 Oct 13. [Epub ahead of print]PMID: 19833491 [PubMed - as supplied by publisher]Related articles

    4.

    Adrenal incidentaloma: a diagnostic challenge.

    Anagnostis P, Karagiannis A, Tziomalos K, Kakafika AI, Athyros VG, Mikhailidis DP.

    Hormones (Athens). 2009 Jul-Sep;8(3):163-84. Review.PMID: 19671516 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention.

    Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP.

    Curr Vasc Pharmacol. 2009 Jul;7(3):264-6. Review.PMID: 19601850 [PubMed - indexed for MEDLINE]Related articles

    6.

    Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study.

    Athyros VG, Hatzitolios A, Karagiannis A, Didangelos TP, Iliadis F, Dolgyras S, Vosnakidis T, Vasiliadis P, Malias I, Tziomalos K, Samouilidou M, Mikhailidis DP; INDEED Collaborative Group.

    Curr Med Res Opin. 2009 Aug;25(8):1931-40.PMID: 19558210 [PubMed - indexed for MEDLINE]Related articles

    7.

    Implementation of guidelines for the management of arterial hypertension. The impulsion study.

    Karagiannis A, Hatzitolios AI, Athyros VG, Deligianni K, Charalambous C, Papathanakis C, Theodosiou G, Drakidis T, Chatzikaloudi V, Kamilali C, Matsiras S, Matziris A, Savopoulos C, Baltatzi M, Rudolf J, Tziomalos K, Mikhailidis DP.

    Open Cardiovasc Med J. 2009 May 5;3:26-34.PMID: 19557149 [PubMed - in process]Related articlesFree article

    8.

    Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?

    Karagiannis A, Tziomalos K, Anagnostis P, Gossios T, Athyros VG.

    Angiology. 2009 Aug-Sep;60(4):397-402. Epub 2009 Jun 7. No abstract available. PMID: 19505885 [PubMed - indexed for MEDLINE]Related articles

    9.

    Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.

    Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP.

    J Clin Endocrinol Metab. 2009 Aug;94(8):2692-701. Epub 2009 May 26. Review.PMID: 19470627 [PubMed - indexed for MEDLINE]Related articles

    10.

    Lipoprotein a: where are we now?

    Tziomalos K, Athyros VG, Wierzbicki AS, Mikhailidis DP.

    Curr Opin Cardiol. 2009 Jul;24(4):351-7.PMID: 19417640 [PubMed - in process]Related articles

    11.

    The role of statins for the primary and secondary prevention of coronary heart disease in women.

    Tziomalos K, Kakafika AI, Athyros VG, Karagiannis A, Mikhailidis DP.

    Curr Pharm Des. 2009;15(10):1054-62. Review.PMID: 19355947 [PubMed - indexed for MEDLINE]Related articles

    12.

    Triglycerides and vascular risk: insights from epidemiological data and interventional studies.

    Tziomalos K, Athyros VG, Karagiannis A, Kolovou GD, Mikhailidis DP.

    Curr Drug Targets. 2009 Apr;10(4):320-7. Review.PMID: 19355856 [PubMed - indexed for MEDLINE]Related articles

    13.

    A comparison of the aldosterone-blocking agents eplerenone and spironolactone.

    Karagiannis A, Athyros VG, Mikhailidis DP.

    Clin Cardiol. 2009 Apr;32(4):230. No abstract available. PMID: 19353701 [PubMed - indexed for MEDLINE]Related articles

    14.

    The JUPITER trial results boost the evidence for the use of hsCRP as a treatment target and as part of the assessment of vascular risk: time for new guidelines?

    Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP.

    Hellenic J Cardiol. 2009 Mar-Apr;50(2):89-91. No abstract available. PMID: 19329409 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Implementation of strategy for the management of overt dyslipidemia: The IMPROVE-dyslipidemia study.

    Hatzitolios AI, Athyros VG, Karagiannis A, Savopoulos C, Charalambous C, Kyriakidis G, Milidis T, Papathanakis C, Bitli A, Vogiatsis I, Ntaios G, Katsiki N, Symeonidis A, Tziomalos K, Mikhailidis DP; IMPROVE Collaborative Group.

    Int J Cardiol. 2009 May 29;134(3):322-9. Epub 2009 Mar 6.PMID: 19268376 [PubMed - in process]Related articles

    16.

    Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study.

    Athyros VG, Karagiannis A, Hatzitolios AI, Paletas K, Savopoulos C, Giannoglou G, Mikhailidis DP; SAGE-METS collaborative group.

    Curr Med Res Opin. 2009 Apr;25(4):971-80.PMID: 19265488 [PubMed - indexed for MEDLINE]Related articles

    17.

    JUPITER: major implications for vascular risk assessment.

    Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP.

    Curr Med Res Opin. 2009 Jan;25(1):133-7.PMID: 19210146 [PubMed - indexed for MEDLINE]Related articles

    18.

    Pleiotropic effects of statins--clinical evidence.

    Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP.

    Curr Pharm Des. 2009;15(5):479-89. Review.PMID: 19199976 [PubMed - indexed for MEDLINE]Related articles

    19.

    Anti-inflammatory effects of fibrates: an overview.

    Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP.

    Curr Med Chem. 2009;16(6):676-84. Review.PMID: 19199931 [PubMed - indexed for MEDLINE]Related articles

    20.

    Targeting triglycerides in secondary prevention: should we bother?

    Athyros VG, Kakafika AI, Wierzbicki AS, Karagiannis A, Mikhailidis DP.

    Int J Clin Pract. 2009 Jan;63(1):15-8. Review. No abstract available. PMID: 19125988 [PubMed - indexed for MEDLINE]Related articles

    21.

    Colesevelam improves glycemic control and lipid management in inadequately controlled type 2 diabetes mellitus.

    Tziomalos K, Athyros VG, Mikhailidis DP.

    Nat Clin Pract Endocrinol Metab. 2009 Jan;5(1):16-7. Epub 2008 Nov 18. No abstract available. PMID: 19015647 [PubMed]Related articles

    22.

    Preventing macrovascular complications of diabetes: where do we stand with glycemic control?

    Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP.

    Expert Opin Investig Drugs. 2008 Dec;17(12):1777-9. No abstract available. PMID: 19012494 [PubMed - indexed for MEDLINE]Related articles

    23.

    Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients.

    Athyros VG, Kakafika AI, Papageorgiou AA, Pagourelias ED, Savvatianos SD, Elisaf M, Karagiannis A, Tziomalos K, Mikhailidis DP.

    Open Cardiovasc Med J. 2007;1:8-14. Epub 2007 Jul 28.PMID: 18949085 [PubMed - in process]Related articlesFree article

    24.

    Omega-3 fatty acids: how can they be used in secondary prevention?

    Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP.

    Curr Atheroscler Rep. 2008 Dec;10(6):510-7. Review.PMID: 18937899 [PubMed - indexed for MEDLINE]Related articles

    25.

    Statin discontinuation: an underestimated risk?

    Tziomalos K, Athyros VG, Mikhailidis DP.

    Curr Med Res Opin. 2008 Sep 29. [Epub ahead of print]PMID: 18826752 [PubMed - as supplied by publisher]Related articles

    26.

    High density lipoprotein cholesterol and statin trials.

    Kakafika A, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP.

    Curr Med Chem. 2008;15(22):2265-70. Review.PMID: 18781948 [PubMed - indexed for MEDLINE]Related articles

    27.

    Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.

    Karagiannis A, Tziomalos K, Kakafika AI, Athyros VG, Harsoulis F, Mikhailidis DP.

    Endocr Relat Cancer. 2008 Sep;15(3):693-700. Epub 2008 Jun 27. Review.PMID: 18586836 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Additional effects of statins in surgical patients.

    Paraskevas KI, Mikhailidis DP, Athyros VG.

    Ann Surg. 2008 Jul;248(1):140-1; author reply 141. No abstract available. PMID: 18580221 [PubMed - indexed for MEDLINE]Related articles

    29.

    Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?

    Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP.

    Expert Opin Ther Targets. 2008 Jul;12(7):809-20. Review.PMID: 18554150 [PubMed - indexed for MEDLINE]Related articles

    30.

    Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster?

    Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP.

    Expert Opin Investig Drugs. 2008 Jul;17(7):969-72.PMID: 18549334 [PubMed - indexed for MEDLINE]Related articles

    31.

    Primary and secondary coronary heart disease prevention using statins: is targeting Adam or Eve equally effective?

    Kakafika AI, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP.

    Expert Opin Pharmacother. 2008 Jun;9(9):1437-40.PMID: 18518775 [PubMed - indexed for MEDLINE]Related articles

    32.

    Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?

    Anagnostis P, Karagiannis A, Kakafika AI, Tziomalos K, Athyros VG, Mikhailidis DP.

    Osteoporos Int. 2009 Feb;20(2):197-207. Epub 2008 May 29. Review.PMID: 18509713 [PubMed - indexed for MEDLINE]Related articles

    33.

    Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia.

    Athyros VG, Kakafika AI, Karagiannis A, Mikhailidis DP.

    Am J Cardiol. 2008 Jun 1;101(11):1679-80. No abstract available. Erratum in: Am J Cardiol. 2008 Jul 15;102(2):248. Koragiannis, Asterios [corrected to Karagiannis, Asterios]; Mikhalidis, Dimitri P [corrected to Mikhailidis, Dimitri P]. PMID: 18489951 [PubMed - indexed for MEDLINE]Related articles

    34.

    Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study.

    Athyros VG, Kakafika AI, Papageorgiou AA, Paraskevas KI, Tziomalos K, Anagnostis P, Pagourelias E, Koumaras C, Karagiannis A, Mikhailidis DP.

    Curr Med Res Opin. 2008 Jun;24(6):1593-9. Epub 2008 Apr 21.PMID: 18430270 [PubMed - indexed for MEDLINE]Related articles

    35.

    Do we need to consider inflammatory markers when we treat atherosclerotic disease?

    Athyros VG, Kakafika AI, Karagiannis A, Mikhailidis DP.

    Atherosclerosis. 2008 Sep;200(1):1-12. Epub 2008 Mar 6. Review.PMID: 18420211 [PubMed - indexed for MEDLINE]Related articles

    36.

    Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?

    Pagourelias ED, Koumaras C, Kakafika AI, Tziomalos K, Zorou PG, Athyros VG, Karagiannis A.

    Angiology. 2009 Feb-Mar;60(1):74-81. Epub 2008 Apr 14. Review.PMID: 18413330 [PubMed - indexed for MEDLINE]Related articles

    37.

    Statins for the prevention of first or recurrent stroke.

    Athyros VG, Kakafika AI, Tziomalos K, Papageorgiou AA, Karagiannis A.

    Curr Vasc Pharmacol. 2008 Apr;6(2):124-33. Review.PMID: 18393914 [PubMed - indexed for MEDLINE]Related articles

    38.

    Atherogenesis in renal patients: a model of vascular disease?

    Efstratiadis G, Tziomalos K, Mikhailidis DP, Athyros VG, Hatzitolios A.

    Curr Vasc Pharmacol. 2008 Apr;6(2):93-107. Review.PMID: 18393910 [PubMed - indexed for MEDLINE]Related articles

    39.

    Has the time come for a new definition of microalbuminuria?

    Karagiannis A, Mikhailidis DP, Tziomalos K, Kakafika AI, Athyros VG.

    Curr Vasc Pharmacol. 2008 Apr;6(2):81-3. No abstract available. PMID: 18393908 [PubMed - indexed for MEDLINE]Related articles

    40.

    Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study.

    Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, Athyrou VV, Kontopoulos AG.

    Clin Drug Investig. 1998;16(3):219-27.PMID: 18370543 [PubMed - in process]Related articles

    41.

    Effect of aldose reductase inhibition on heart rate variability in patients with severe or moderate diabetic autonomic neuropathy.

    Didangelos TP, Athyros VG, Karamitsos DT, Papageorgiou AA, Kourtoglou GI, Kontopoulos AG.

    Clin Drug Investig. 1998;15(2):111-21.PMID: 18370475 [PubMed - in process]Related articles

    42.

    Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?

    Athyros VG, Kakafika A, Tziomalos K, Karagiannis A, Mikhailidis DP.

    Expert Opin Investig Drugs. 2008 Apr;17(4):445-9.PMID: 18363511 [PubMed - indexed for MEDLINE]Related articles

    43.

    Unusual manifestation of diarrhea-associated haemolytic uraemic syndrome in an adult.

    Anagnostis P, Stangou M, Leontsini M, Athyros VG, Karagiannis A.

    Ren Fail. 2008;30(3):331-4.PMID: 18350454 [PubMed - indexed for MEDLINE]Related articles

    44.

    CORONA, statins, and heart failure: who lost the crown?

    Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP.

    Angiology. 2008 Feb-Mar;59(1):5-8. No abstract available. PMID: 18319216 [PubMed - indexed for MEDLINE]Related articles

    45.

    Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.

    Athyros VG, Tziomalos K, Kakafika AI, Koumaras H, Karagiannis A, Mikhailidis DP.

    Am J Cardiol. 2008 Feb 15;101(4):483-5. Epub 2007 Dec 20.PMID: 18312762 [PubMed - indexed for MEDLINE]Related articles

    46.

    Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.

    Karagiannis A, Tziomalos K, Papageorgiou A, Kakafika AI, Pagourelias ED, Anagnostis P, Athyros VG, Mikhailidis DP.

    Expert Opin Pharmacother. 2008 Mar;9(4):509-15.PMID: 18312153 [PubMed - indexed for MEDLINE]Related articles

    47.

    Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.

    Athyros VG, Liberopoulos EN, Mikhailidis DP, Papageorgiou AA, Ganotakis ES, Tziomalos K, Kakafika AI, Karagiannis A, Lambropoulos S, Elisaf M.

    Angiology. 2007 Dec-2008 Jan;58(6):689-97.PMID: 18216378 [PubMed - indexed for MEDLINE]Related articles

    48.

    Pheochromocytoma: an update on genetics and management.

    Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F.

    Endocr Relat Cancer. 2007 Dec;14(4):935-56. Review.PMID: 18045948 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Fish oils and vascular disease prevention: an update.

    Tziomalos K, Athyros VG, Mikhailidis DP.

    Curr Med Chem. 2007;14(24):2622-8. Review.PMID: 17979714 [PubMed - indexed for MEDLINE]Related articles

    50.

    Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?

    Athyros VG, Tziomalos K, Mikhailidis DP, Pagourelias ED, Kakafika AI, Skaperdas A, Hatzitolios A, Karagiannis A.

    Expert Opin Pharmacother. 2007 Oct;8(14):2267-77. Review.PMID: 17927482 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...